US Patent 8410189 Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
Patent 8410189 was granted and assigned to HyperBranch Medical Technology on April, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8410189 Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.